GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calithera Biosciences Inc (STU:2CB0) » Definitions » Price-to-Tangible-Book

Calithera Biosciences (STU:2CB0) Price-to-Tangible-Book : (As of May. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Calithera Biosciences Price-to-Tangible-Book?

As of today (2024-05-11), Calithera Biosciences's share price is €0.045. Calithera Biosciences's Tangible Book per Share of Dec. 2022 for the quarter that ended in Dec. 2022 was €-0.38. Hence, Calithera Biosciences's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Calithera Biosciences's Price-to-Tangible-Book or its related term are showing as below:

STU:2CB0's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.7
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Calithera Biosciences's share price is €0.045. Calithera Biosciences's Book Value per Sharefor the quarter that ended in Dec. 2022 was €-0.38. Hence, Calithera Biosciences's P/B Ratio of today is .


Calithera Biosciences Price-to-Tangible-Book Historical Data

The historical data trend for Calithera Biosciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calithera Biosciences Price-to-Tangible-Book Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 2.68 3.39 5.62 -

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.62 - 1.02 3.55 -

Competitive Comparison of Calithera Biosciences's Price-to-Tangible-Book

For the Biotechnology subindustry, Calithera Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Calithera Biosciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calithera Biosciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Calithera Biosciences's Price-to-Tangible-Book falls into.



Calithera Biosciences Price-to-Tangible-Book Calculation

Calithera Biosciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2022 )
=0.045/-0.378
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Calithera Biosciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Calithera Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Calithera Biosciences (STU:2CB0) Business Description

Traded in Other Exchanges
N/A
Address
343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the United States. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Calithera Biosciences (STU:2CB0) Headlines

No Headlines